{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:25:58Z","timestamp":1779135958731,"version":"3.51.4"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"66","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,8,24]]},"DOI":"10.18632\/oncotarget.26024","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T19:12:42Z","timestamp":1535137962000},"page":"32718-32729","source":"Crossref","is-referenced-by-count":12,"title":["A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis"],"prefix":"10.18632","volume":"9","author":[{"given":"Jessie","family":"Gills","sequence":"first","affiliation":[{"name":"Department of Urology, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravan","family":"Moret","sequence":"additional","affiliation":[{"name":"Institution of Translational Research, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institution of Translational Research, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Urology, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Maresh","sequence":"additional","affiliation":[{"name":"Institution of Translational Research, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linh","family":"Hellmers","sequence":"additional","affiliation":[{"name":"Institution of Translational Research, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Canter","sequence":"additional","affiliation":[{"name":"Department of Urology, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u2019Liss","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Urology, Ochsner Clinic Foundation, New Orleans, LA, USA"},{"name":"Current address: Memorial Urology Associates, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shams","family":"Halat","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Matrana","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Marino","sequence":"additional","affiliation":[{"name":"Division of Cellular and Gene Therapies, The Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Reiser","sequence":"additional","affiliation":[{"name":"Division of Cellular and Gene Therapies, The Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Shuh","sequence":"additional","affiliation":[{"name":"Institution of Translational Research, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Laborde","sequence":"additional","affiliation":[{"name":"Department of Urology, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Latsis","sequence":"additional","affiliation":[{"name":"Department of Urology, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Talwar","sequence":"additional","affiliation":[{"name":"Department of Urology, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Bardot","sequence":"additional","affiliation":[{"name":"Department of Urology, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Institution of Translational Research, Ochsner Clinic Foundation, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"key":"1","unstructured":"National Cancer Institute. SEER Stat Fact Sheets: Bladder Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html. 2018. Accessed May 16, 2018."},{"key":"2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.eururo.2012.02.028","article-title":"Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients","volume":"61","author":"Volkmer","year":"2012","journal-title":"Eur Urol"},{"key":"4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Skinner","year":"2001","journal-title":"J Clin Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-5347(17)36200-6","article-title":"The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results","volume":"149","author":"Hopwood","year":"1993","journal-title":"J Urol"},{"key":"6","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0022-5347(01)62229-8","article-title":"Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall","volume":"160","author":"Steven","year":"1998","journal-title":"J Urol"},{"key":"7","first-page":"1602","article-title":"Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial","volume":"163","author":"Droller","year":"2000","journal-title":"J Urol"},{"key":"8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.eururo.2008.10.016","article-title":"Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer","volume":"55","author":"Sternberg","year":"2009","journal-title":"Eur Urol"},{"key":"9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Crawford","year":"2003","journal-title":"N Engl J Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(99)02292-8","article-title":"Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists","volume":"354","author":"Trialists","year":"1999","journal-title":"Lancet"},{"key":"11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.urology.2006.10.041","article-title":"Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer","volume":"69","author":"Soloway","year":"2007","journal-title":"Urology"},{"key":"12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.urolonc.2016.10.004","article-title":"A review of the PD-1\/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment","volume":"35","author":"Zang","year":"2017","journal-title":"Urol Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.critrevonc.2015.10.021","article-title":"Novel therapeutic targets in advanced urothelial carcinoma","volume":"98","author":"Soria","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research","volume":"4","author":"Trusolino","year":"2014","journal-title":"Cancer Discov"},{"key":"15","doi-asserted-by":"publisher","first-page":"71696","DOI":"10.18632\/oncotarget.12322","article-title":"Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy","volume":"7","author":"Hoffman","year":"2016","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1096\/fj.14-268938","article-title":"The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model","volume":"29","author":"Li","year":"2015","journal-title":"FASEB J"},{"key":"17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Ward","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.urolonc.2010.04.008","article-title":"Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression","volume":"28","author":"Czerniak","year":"2010","journal-title":"Urol Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.urolonc.2009.04.019","article-title":"Molecular pathways of urothelial development and bladder tumorigenesis","volume":"28","author":"Cordon-Cardo","year":"2010","journal-title":"Urol Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"14016","DOI":"10.1073\/pnas.0906549106","article-title":"Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells","volume":"106","author":"Weissman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1464-410X.2002.03053.x","article-title":"'Superficial' bladder cancer - time to uncouple pT1 tumours from pTa tumours","volume":"90","author":"Wallace","year":"2002","journal-title":"BJU Int"},{"key":"22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10555-009-9189-4","article-title":"Biology of urothelial tumorigenesis: insights from genetically engineered mice","volume":"28","author":"Wu","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1101\/gad.1772909","article-title":"Inactivation of p53 and Pten promotes invasive bladder cancer","volume":"23","author":"Abate-Shen","year":"2009","journal-title":"Genes Dev"},{"key":"24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2141.2012.09123.x","article-title":"A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential","volume":"158","author":"Li","year":"2012","journal-title":"Br J Haematol"},{"key":"25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/107327481702400113","article-title":"Urothelial Carcinoma With Squamous Differentiation Is Associated With High Tumor Stage and Pelvic Lymph-Node Metastasis","volume":"24","author":"Xu","year":"2017","journal-title":"Cancer Control"},{"key":"26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Weinberg","year":"2000","journal-title":"Cell"},{"key":"27","doi-asserted-by":"crossref","first-page":"e59536","DOI":"10.1371\/journal.pone.0059536","article-title":"Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach","volume":"8","author":"Black","year":"2013","journal-title":"PloS One"},{"key":"28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0022-5347(01)69134-1","article-title":"Use of green fluorescent protein to measure tumor growth in an implanted bladder tumor model","volume":"167","author":"Torti","year":"2002","journal-title":"J Urol"},{"key":"29","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/S0022-5347(01)66923-4","article-title":"Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice","volume":"154","author":"Killion","year":"1995","journal-title":"J Urol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1464-410X.2007.07165.x","article-title":"A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging","volume":"100","author":"So","year":"2007","journal-title":"BJU Int"},{"key":"31","first-page":"3051","article-title":"Technical factors affecting the reproducibility of intravesical mouse bladder tumor implantation during therapy with Bacillus Calmette-Guerin","volume":"44","author":"Ratliff","year":"1984","journal-title":"Cancer Res"},{"key":"32","first-page":"1611","article-title":"Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guerin and its correlation with Bacillus Calmette-Guerin viability and natural killer cell activity","volume":"43","author":"Catalona","year":"1983","journal-title":"Cancer Res"},{"key":"33","first-page":"3726","article-title":"Modulation of fibronectin-mediated Bacillus Calmette-Guerin attachment to murine bladder mucosa by drugs influencing the coagulation pathways","volume":"51","author":"Ratliff","year":"1991","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0022-5347(17)45139-1","article-title":"Improved growth of human urothelial carcinoma cell cultures","volume":"136","author":"Cox","year":"1986","journal-title":"J Urol"},{"key":"35","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.4049\/jimmunol.153.7.2951","article-title":"Activation and proliferation of follicular dendritic cell-like cells by activated T lymphocytes","volume":"153","author":"Choi","year":"1994","journal-title":"J Immunol"},{"key":"36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1593\/neo.11324","article-title":"Lymph node stromal cells enhance drug-resistant colon cancer cell tumor formation through SDF-1alpha\/CXCR4 paracrine signaling","volume":"13","author":"Li","year":"2011","journal-title":"Neoplasia"},{"key":"37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4049\/jimmunol.155.3.1101","article-title":"Stimulation of germinal center B lymphocyte proliferation by an FDC-like cell line, HK","volume":"155","author":"Choi","year":"1995","journal-title":"J Immunol"},{"key":"38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/hgtb.2012.054","article-title":"Specific targeting of human interleukin (IL)-13 receptor alpha2-positive cells with lentiviral vectors displaying IL-13","volume":"23","author":"Reiser","year":"2012","journal-title":"Hum Gene Ther Methods"},{"key":"39","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/gt.2008.90","article-title":"Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition","volume":"15","author":"Morgan","year":"2008","journal-title":"Gene Ther"},{"key":"40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nprot.2009.22","article-title":"Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors","volume":"4","author":"Reiser","year":"2009","journal-title":"Nat Protoc"},{"key":"41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jviromet.2008.11.021","article-title":"Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection","volume":"157","author":"Reiser","year":"2009","journal-title":"J Virol Methods"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T15:34:29Z","timestamp":1693841669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":41,"journal-issue":{"issue":"66","published-print":{"date-parts":[[2018,8,24]]}},"alternative-id":["26024","30220977"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26024","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]}}}